Dean C Singleton (D C Singleton)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Endoplasmic Reticulum

Top Venues

Nature reviews. Clinical oncology

Cancer gene therapy

Genes to cells : devoted to molecular & cellular mechanisms

University of Auckland

University of Auckland (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Auckland

New Zealand

Research Fellow :: Auckland Cancer Society Research Centre

University of Oxford

United Kingdom

Postdoctoral Research Fellow :: Nuffield Department of Medicine

University of Oxford

United Kingdom

Postdoctoral Research Fellow :: Department of Oncology

Education History

University of Auckland

New Zealand

PHD :: Molecular Medicine and Pathology

Publications

M Faiz, Maggie L Kalev-Zylinska, Caitlin Dunstan-Harrison, Dean C Singleton, Michael P Hay, Elizabeth C Ledgerwood
Megakaryocyte maturation involves activation of the adaptive unfolded protein response. Genes to cells : devoted to molecular & cellular mechanisms (2024)
Gary J Cheng, Euphemia Y Leung, Dean C Singleton
In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy. Exploration of targeted anti-tumor therapy 3 (3) (2022)
Dean C Singleton, Alexandra M Mowday, Chris P Guise, Sophie P Syddall, Sally Y Bai, Dan Li, Amir Ashoorzadeh, Jeff B Smaill, William R Wilson, Adam V Patterson
Bioreductive prodrug PR-104 improves the tumour distribution and titre of the nitroreductase-armed oncolytic adenovirus ONYX-411NTR leading to therapeutic benefit. Cancer gene therapy (2021)
Dean C Singleton, Andrew Macann, William R Wilson
Therapeutic targeting of the hypoxic tumour microenvironment. Nature reviews. Clinical oncology 18 (12) (2021)
Dean C Singleton, Anne-Lise Dechaume, Pamela M Murray, William P Katt, Bruce C Baguley, Euphemia Y Leung
Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer. BMC cancer 20 (1) (2020)
Lydia P Liew, Dean C Singleton, Way W Wong, Gary J Cheng, Stephen M F Jamieson, Michael P Hay
Hypoxia-Activated Prodrugs of PERK Inhibitors. Chemistry, an Asian journal 14 (8) (2019)